
BreastCancerResearch
@bcrjournal
Breast Cancer Research is an international peer-reviewed open access journal publishing original research, reviews, editorials & reports.
ID: 4067528475
https://go.sn.pub/KgZBoP 29-10-2015 11:57:51
379 Tweet
1,1K Takipçi
330 Takip Edilen

Identifying patterns in circulating tumor cells may reduce risk of brain metastases in #breastcancer #patients: bit.ly/2lAoMLs #cancerresearch #openaccess #TuesdayThoughts MPI for Molecular Genetics



New research: Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative #breastcancer: bit.ly/2nSRNDp Hospital Clínic SOLTI #cancerresearch #MondayMorning




New research on a masking risk model to make better use of a #mammogram: bit.ly/2nR9Km2 UVA Health Sunnybrook Health Sciences Centre #breastcancerawareness #BreastCancerMonth #WednesdayWisdom


Predicting #breastcancer risk of recurrence with #MachineLearning: bit.ly/2nDOm3X #breastcancerawareness #WednesdayWisdom Georgia State University Emory University Uni of Nottingham #WeAreUoN Cedars-Sinai


In recognition of #BreastCancerAwarenessMonth, Springer Nature is proud to present carefully curated collections on breast cancer from our authors & editors. All content is free to read through October 31 2019. bit.ly/2oJFOZu #breastcancerawareness


The association of BMPs and antagonists to #breastcancer may be a form of targeted therapy for patients: bit.ly/2ognQh3 #Genomics #Analytics #openaccess Oncode Institute Erasmus MC @unimelb #FridayMotivation #BreastCancerAwarenessMonth









'The safety profile of leronlimab, together with strong preclinical evidence to both prevent and reduce established breast cancer metastasis herein, suggests studies of clinical efficacy may be warranted.' Read for free #OA: …ast-cancer-research.biomedcentral.com/articles/10.11… #leronlimab #metastasis

RT Dr Wendy Ingman: Adding another piece to the puzzle of how #breastcancer risk is determined. In mice, we show that macrophages can change their function and this affects susceptibility to mammary cancer. RRI Director Sarah Bernhardt bit.ly/32N2RTD

